C. Laurent

发表

Protein Tyrosine Phosphatase 4A3 (PTP4A3) Is Required for Xenopus laevis Cranial Neural Crest Migration In Vivo

S. Saule, Selma Maacha, N. Planque, 2013, PloS one.

High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients.

E. Barillot, J. Thiery, S. Roman-Roman, 2011, Cancer research.

Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes

C. Laurent, Sake I. van Pelt, G. Luyten, 2016, PloS one.

New insight for pharmacogenomics studies from the transcriptional analysis of two large-scale cancer cell line panels

P. Neuvial, P. Gestraud, F. Reyal, 2017, Scientific Reports.

A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways

M. Moarii, F. Reyal, C. Laurent, 2016, PLoS ONE.

Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis

M. Moarii, F. Reyal, C. Laurent, 2016, Oncoimmunology.

Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors

E. Barillot, S. Roman-Roman, L. Desjardins, 2010, Clinical Cancer Research.

A large collection of integrated genomically characterized patient‐derived xenografts highlighting the heterogeneity of triple‐negative breast cancer

A. Vincent-Salomon, S. Vacher, S. Château-Joubert, 2019, International journal of cancer.

Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data

Jean-Philippe Vert, F. Reyal, C. Laurent, 2018, bioRxiv.

Patient‐derived xenografts recapitulate molecular features of human uveal melanomas

E. Barillot, A. Nicolas, S. Roman-Roman, 2013, Molecular Oncology.

Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers

M. Piccart, A. Vincent-Salomon, S. Vacher, 2018, Clinical Cancer Research.

Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma

C. Emery, S. Roman-Roman, Ensar Halilovic, 2016, Oncotarget.

PTP4A3, a Signal Molecule Deregulated in Uveal Melanoma Metastasis

E. Barillot, L. Desjardins, S. Saule, 2010 .

Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression.

A. Vincent-Salomon, O. Delattre, R. Rouzier, 2018, The American journal of pathology.

New insight for pharmacogenomics studies from the transcriptional analysis of two large-scale cancer cell line panels

P. Neuvial, P. Gestraud, F. Reyal, 2017, Scientific Reports.

EMA - A R package for Easy Microarray data analysis

Emmanuel Barillot, Nicolas Servant, Philippe Hupé, 2010, BMC Research Notes.

EMA-Easy Microarray data Analysis

P. Gestraud, E. Barillot, B. Asselain, 2010 .

Luminal Progenitors Restrict Their Lineage Potential during Mammary Gland Development

F. Reyal, C. Laurent, S. Fre, 2015, PLoS biology.

Evolution of synchronous female bilateral breast cancers and response to treatment

O. Mariani, A. Vincent-Salomon, S. Vacher, 2023, Nature Medicine.

Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data

Jean-Philippe Vert, Fabien Reyal, Judith Abécassis, 2018, bioRxiv.

Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer

A. Vincent-Salomon, R. Rouzier, F. Reyal, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

A. Witteveen, A. Glas, L. Delahaye, 2019, Translational oncology.

Supplementary Methods 1.1 Data 1.1.1 Training and Validation Sets

M. Moarii, F. Reyal, C. Laurent, 2022 .

Protein Tyrosine Phosphatase 4A3 (PTP4A3) Promotes Human Uveal Melanoma Aggressiveness Through Membrane Accumulation of Matrix Metalloproteinase 14 (MMP14).

S. Saule, G. Liot, S. Piperno-Neumann, 2016, Investigative ophthalmology & visual science.

Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) promotes the aggressiveness of human uveal melanoma through dephosphorylation of CRMP2

S. Saule, N. Planque, C. Laurent, 2019, Scientific Reports.

Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) promotes the aggressiveness of human uveal melanoma through dephosphorylation of CRMP2

S. Saule, N. Planque, C. Laurent, 2019, Scientific Reports.

New insight for pharmacogenomics studies from the transcriptional analysis of two large-scale cancer cell line panels

P. Neuvial, P. Gestraud, F. Reyal, 2017, Scientific Reports.

Patient‐derived xenografts recapitulate molecular features of human uveal melanomas

E. Barillot, A. Nicolas, S. Roman-Roman, 2013, Molecular oncology.

High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients.

E. Barillot, J. Thiery, S. Roman-Roman, 2011, Cancer research.

Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression.

A. Vincent-Salomon, O. Delattre, R. Rouzier, 2018, The American journal of pathology.

A large collection of integrated genomically characterized patient‐derived xenografts highlighting the heterogeneity of triple‐negative breast cancer

A. Vincent-Salomon, S. Vacher, I. Bièche, 2019, International journal of cancer.

Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers

M. Piccart, A. Vincent-Salomon, S. Vacher, 2018, Clinical Cancer Research.